| |
1:Crude
|
2: Model 1 + Age + gender + social class
|
3: Model 2 + PFT
|
4: Model 3 + Illness
|
|---|
|
β
a
[95% CI]
|
p-value
|
β [95% CI]
|
p-value
|
β [95% CI]
|
p-value
|
β [95% CI]
|
p-value
|
|---|
|
PCSb, c
|
−3.24 [−5.95-(−0.53)]
|
0.019
|
−3.87 [−6.40-(−1.33)]
|
0.003
|
−2.66 [−5.18-(−0.13)]
|
0.039
|
−2.60 [−5.10-(−0.11)]
|
0.041
|
|
MCSb,d
|
−0.81 [−3.22-1.60]
|
0.509
|
−0.75 [−3.18-1.69]
|
0.547
|
−0.78 [−3.28-1.72]
|
0.541
|
−0.77 [−3.27-1.74]
|
0.547
|
|
OHIPe,f
|
10.62 [6.30-17.90]
|
<0.001
|
11.44 [6.69-19.55]
|
<0.001
|
11.78 [6.86-20.21]
|
<0.001
|
11.63 [6.77-20.01]
|
<0.001
|
|
OIDPe,g
|
18.82 [10.37-34.15]
|
<0.001
|
21.07 [11.48-38.63]
|
<0.001
|
21.14 [11.52-38.82]
|
<0.001
|
21.26 [11.54-39.13]
|
<0.001
|
-
aDifferences between oral cancer survivors (n = 142) and controls (n = 142); bLinear regression; cPCS: Physical Component Summary; dMCS: Mental Component Summary; eOrdinal logistic regression; fOHIP: Oral Health Impact Profile; gOIDP: Oral Impacts on Daily Performances.
